WSJ News Exclusive | U.S. National Security Panel Examining Chinese Investors’ Purchase of Pharma Firm

United States News News

WSJ News Exclusive | U.S. National Security Panel Examining Chinese Investors’ Purchase of Pharma Firm
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

WSJ News Exclusive: U.S. officials are reviewing the 2017 acquisition of a South Carolina pharmaceutical company by Chinese investors after learning it was in talks with the Pentagon over a project involving injection devices for a coronavirus vaccine

WASHINGTON—U.S. national security officials are reviewing the 2017 acquisition of a South Carolina pharmaceutical company by Chinese investors after learning the firm was in talks to participate in a Pentagon project to develop injection devices for a coronavirus vaccine, according to defense officials and others familiar with the matter.

The Committee on Foreign Investment in the U.S.’s inquiry into the acquisition of Ritedose Corp. of Columbia, S.C., was confirmed by the Pentagon’s Defense Logistics Agency, which earlier...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | GoPro Founder Wants $20 Million for 150-Acre California RanchWSJ News Exclusive | GoPro Founder Wants $20 Million for 150-Acre California RanchWSJ News Exclusive: The founder of action camera maker GoPro is listing his 150-acre ranch near Santa Cruz, Calif., for $20 million
Read more »

WSJ News Exclusive | German Biotech Sees Its Coronavirus Vaccine Ready for Approval by DecemberWSJ News Exclusive | German Biotech Sees Its Coronavirus Vaccine Ready for Approval by DecemberBioNTech, which has partnered with Pfizer to develop a coronavirus vaccine, is confident it will be ready to seek regulatory approval by the end of the year, its chief executive said. Several hundred million doses could be produced even before approval, and over 1 billion by the end of 2021.
Read more »

WSJ News Exclusive | American Airlines Has Threatened to Cancel Some Boeing 737 MAX OrdersWSJ News Exclusive | American Airlines Has Threatened to Cancel Some Boeing 737 MAX OrdersAmerican Airlines has threatened to cancel some of its orders for Boeing Co.’s troubled 737 MAX jets, people familiar with the matter said, a sign of deepening financial stress in the aviation industry.
Read more »

Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end: WSJPfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end: WSJBioNTech SE and Pfizer Inc's COVID-19 vaccine candidate is expected to be ready to seek regulatory approval by the end of 2020, the Wall Street Journal reported on Friday, citing the German biotech firm's chief executive officer.
Read more »

American Airlines threatens to cancel some Boeing 737 MAX orders: WSJAmerican Airlines threatens to cancel some Boeing 737 MAX orders: WSJAmerican Airlines Group Inc has threatened to cancel some of its orders for Boeing Co's grounded 737 MAX jets unless the planemaker helps secure funding for them, the Wall Street Journal reported on Friday.
Read more »



Render Time: 2025-03-10 12:24:44